A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages
Persistent activation of macrophages (MP)s into a proinflammatory M1 or anti-inflammatory M2 phenotype plays a role in several pathological conditions, including autoimmune diseases, fibrosis, infections, atherosclerosis and tumor development. The mannose receptor (MR, CD206), expressed at low level...
Main Authors: | Peiming Chen, Xiaoping Zhang, Alessandro Venosa, In Heon Lee, Daniel Myers, Jennifer A. Holloway, Robert K. Prud’homme, Dayuan Gao, Zoltan Szekely, Jeffery D. Laskin, Debra L. Laskin, Patrick J. Sinko |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/3/243 |
Similar Items
-
Mannosylated Polyrotaxanes for Increasing Cellular Uptake Efficiency in Macrophages through Receptor-Mediated Endocytosis
by: Kai Shibaguchi, et al.
Published: (2019-01-01) -
Mannosylated Systems for Targeted Delivery of Antibacterial Drugs to Activated Macrophages
by: Igor D. Zlotnikov, et al.
Published: (2022-12-01) -
(-)-Epigallocatechin-3-gallate (EGCG) modulates polarized macrophages to suppress M1 phenotype and promote M2 polarization in vitro and in vivo
by: Yaozhong Hu, et al.
Published: (2021-12-01) -
Extracellular Vesicle/Macrophage Axis: Potential Targets for Inflammatory Disease Intervention
by: Desheng Tang, et al.
Published: (2022-06-01) -
In Vivo siRNA Delivery to Immunosuppressive Liver Macrophages by α-Mannosyl-Functionalized Cationic Nanohydrogel Particles
by: Leonard Kaps, et al.
Published: (2020-08-01)